Total Payments
$643.10
2024 Payments
$158.60
Companies
15
Transactions
23
Medicare Patients
1,990
Medicare Billing
$330,687
Payment Breakdown by Category
Food & Beverage$643.10 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $643.10 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $162.26 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $93.17 | 1 | $0 (2023) |
| SANOFI PASTEUR INC. | $71.80 | 4 | $0 (2024) |
| Exact Sciences Corporation | $60.97 | 3 | $0 (2024) |
| Edwards Lifesciences Corporation | $59.98 | 1 | $0 (2020) |
| ABBVIE INC. | $32.50 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.55 | 2 | $0 (2024) |
| Ardelyx, Inc. | $25.35 | 1 | $0 (2024) |
| Celltrion USA Inc. | $25.11 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.37 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $158.60 | 8 | Exact Sciences Corporation ($48.01) |
| 2023 | $217.73 | 8 | AstraZeneca Pharmaceuticals LP ($93.17) |
| 2020 | $59.98 | 1 | Edwards Lifesciences Corporation ($59.98) |
| 2018 | $12.15 | 1 | Amarin Pharma Inc. ($12.15) |
| 2017 | $194.64 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($162.26) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 02/07/2024 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Vaccines | ||||||
| 01/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Gastroenterology | ||||||
| 01/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: VACCINES | ||||||
| 11/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Gastroenterology | ||||||
| 09/13/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Vaccines | ||||||
| 09/08/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/24/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Oncology | ||||||
| 08/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $93.17 | General |
| 08/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/31/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Vaccines | ||||||
| 02/13/2020 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $59.98 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/20/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/12/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: DIABETES | ||||||
| 08/01/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: DIABETES | ||||||
| 05/08/2017 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: VIMOVO | ||||||
| 04/04/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: DIABETES | ||||||
| 01/17/2017 | SANOFI PASTEUR INC. | PENTACEL (Drug), FLUZONE HIGH-DOSE, ADACEL | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 503 | 1,542 | $188,845 | $104,505 |
| 2022 | 8 | 440 | 1,332 | $158,765 | $87,381 |
| 2021 | 12 | 566 | 1,648 | $175,850 | $83,275 |
| 2020 | 7 | 481 | 1,273 | $135,700 | $55,526 |
Total Patients
1,990
Total Services
5,795
Medicare Billing
$330,687
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 95 | 805 | $60,375 | $40,644 | 67.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 327 | $65,400 | $32,488 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 84 | 84 | $21,000 | $12,225 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 163 | $24,450 | $9,366 | 38.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 14 | $4,200 | $3,326 | 79.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,300 | $2,042 | 61.9% |
| G3003 | Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) | Office | 2023 | 51 | 59 | $4,425 | $1,509 | 34.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,200 | $1,312 | 41.0% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 14 | 14 | $1,050 | $1,007 | 95.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $400.00 | $392.00 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $825.00 | $118.44 | 14.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 22 | 22 | $220.00 | $75.82 | 34.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 100 | 705 | $52,875 | $35,172 | 66.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 239 | $47,800 | $24,271 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 233 | $34,950 | $13,331 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $16,500 | $9,852 | 59.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $4,200 | $2,658 | 63.3% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 20 | 20 | $1,500 | $1,371 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $650.00 | $637.00 | 98.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 29 | 29 | $290.00 | $88.43 | 30.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 114 | 879 | $65,925 | $27,400 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 215 | $43,000 | $22,451 | 52.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 224 | $33,600 | $13,149 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 64 | 64 | $16,000 | $9,713 | 60.7% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 48 | 48 | $3,600 | $3,132 | 87.0% |
About Dr. Harleen Kaur, M.D
Dr. Harleen Kaur, M.D is a Family Medicine healthcare provider based in Parlin, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1922267012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harleen Kaur, M.D has received a total of $643.10 in payments from pharmaceutical and medical device companies, with $158.60 received in 2024. These payments were reported across 23 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($643.10).
As a Medicare-enrolled provider, Kaur has provided services to 1,990 Medicare beneficiaries, totaling 5,795 services with total Medicare billing of $330,687. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Parlin, NJ
- Active Since 06/04/2008
- Last Updated 11/08/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922267012
Products in Payments
- JARDIANCE (Drug) $162.26
- Cologuard Collection Kit (Device) $60.97
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $59.98
- FLUZONE HIGH-DOSE (Biological) $53.36
- DUOPA (Drug) $32.50
- XIFAXAN (Drug) $27.55
- IBSRELA (Drug) $25.35
- VEGZELMA (Biological) $25.11
- PENTACEL (Drug) $18.44
- ENTYVIO (Biological) $15.37
- SHINGRIX (Biological) $14.81
- VOQUEZNA (Drug) $14.45
- VIMOVO (Drug) $13.94
- PAXLOVID (Drug) $13.69
- Vascepa (Drug) $12.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.